Written By JADED MARE
The FDA right this minute thinks that horses are companion animals.
Of course, we don’t kill companion animals, except all the time, but not to eat later unless you are a horse because foreigners in other countries think horse flesh tastes real yummy, especially American brand.
Hmmm. Would these drugs fall into the category of not to be used on animals for human consumption? Oh, suppose they forgot or something; they don’t say or who makes the stuff. Not that it seems to matter, also. You could ask Germaine, but she’s probably not telling or just don’t know, it’s not her job or something to think about those things.
On December 17, 2008, the Food and Drug Administration (FDA) published in the Federal Register the availability of a draft guidance document for industry entitled “Guidance for Industry #192: Anesthetics for Companion Animals.” The comment period for the guidance closes on March 2, 2009.
The purpose of the guidance document is to provide industry with FDA’s recommendations for the development of new animal anesthetic drug products for companion animals (dogs, cats, and horses.) (emphasis added)
The guidance discusses information that sponsors should consider when planning and conducting safety and field studies for their proposed drug product. The guidance also provides recommendations on how to analyze the study data and how to present the collected data in an organized package to CVM.
The draft guidance, once finalized, will represent the Agency’s current thinking on the development of companion animal general anesthetic (injectable or inhalational) drug products.
Interested persons may submit written comments on or before March 2, 2009, to the Division of Dockets Management (HFA-305), FDA, 5630 Fishers Lane, Room 1061, Rockville, MD 20852. Electronic comments may be submitted to: http://www.regulations.gov/. Identify all submissions to the docket with the following docket number: 2008D-0623.
For additional information about the draft guidance, please contact Dr. Germaine Connolly at FDA’s Center for Veterinary Medicine, 240-276-8331, firstname.lastname@example.org.